Evaluation of kidney grafts with 99mTc-methylene diphosphonate within 36 hours after transplantation: A marker of ischemic damage
- 1 March 1984
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 9 (3) , 115-120
- https://doi.org/10.1007/bf00253512
Abstract
In order to evaluate renal ischemic damage in transplanted kidneys, renal scintigraphy with 99mTc-methylene disphosphonate was performed in 30 kidney grafts within 36 h after transplantation. The renal uptake was monitored for 100 s at 10-min intervals during 90 min following injection. Seventeen patients had an average uptake of radioactivity in the kidney on the 60-, 70-, 80-, and 90-min scintigrams expressed as a percentage of the activity present on the 10-min scintigram of 150% or less (low) and 13 patients had an average uptake of radioactivity of above 150% (high). There was no relationship between the average uptake of radioactivity and warm and cold ischemia times (or the combined value: corrected ischemia), maximal function, reversible rejection, and ureteral obstruction. A significant correlation was found between the average uptake of radioactivity in the kidney and onset of function. Seventy-six per cent of the grafts with a low average uptake of radioactivity had an onset of function on or before day 10 after operation (early) whereas only 15% of the kidneys with a high average uptake of radioactivity had an early onset of function. Twelve per cent of the patients with a low average uptake of radioactivity in the kidneys had their grafts removed for various reasons within 2 months after transplantation, whereas 54% with a high average uptake of radioactivity had their grafts removed. It is concluded that 99mTc-methylene diphosphonate scintigraphy may be useful in the prognostic assessment of graft onset of function and of graft survival.Keywords
This publication has 16 references indexed in Scilit:
- Evaluation of renal ischemia with 99mTc-pyrophosphateEuropean Journal of Nuclear Medicine and Molecular Imaging, 1982
- Quantitation of Ischemic Injury with 99mTc-HEDP in Experimental Acute Tubular NecrosisInvestigative Radiology, 1980
- Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphySeminars in Nuclear Medicine, 1980
- Pyrophosphate Retention by Previously Irradiated Renal TissueRadiology, 1979
- Renal Hyperconcentration of99mTc-HEDP in Experimental Acute Tubular NecrosisRadiology, 1979
- Intense Concentration of Technetium-99m Pyrophosphate in the Kidneys of Children Treated with Chemotherapeutic Drugs for Malignant DiseaseRadiology, 1978
- Sites and Mechanisms of Localization of Technetium-99m Phosphorus Radiopharmaceuticals in Acute Myocardial Infarcts and other TissuesJournal of Clinical Investigation, 1977
- Mechanisms contributing to myocardial accumulation of technetium-99m stannous pyrophosphate after coronary arterial occlusionThe American Journal of Cardiology, 1977
- CLINICAL EXPERIENCES WITH PRESERVATION OF NECROKIDNEYSActa Medica Scandinavica, 1973
- Kidney Preservation for TransportationNew England Journal of Medicine, 1971